Manuel Heras
Hospital Clínico San Carlos
24 Papers
113 Citations
Manuel Heras is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Chemoradiotherapy & Patiromer. The author has an hindex of 6, co-authored 24 publications.
Chat about Author
Papers
Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer.
Alejandro de la Torre,Salvador Ramos,Francisco Valcárcel,Arturo Candal,C.A. Regueiro,Jesús Romero,R. Magallón,J Salinas,Manuel Heras,C. Veiras,Jose Luis Tisaire,G. Aragón +11 more
TL;DR: The response rates achieved with this schedule seem comparable to those obtained with 5-FU and radiotherapy, and warrant further evaluation of this combination in patients with unresectable or locally advanced tumors.
61
Long-term Changes in Pulmonary Function After Incidental Lung Irradiation for Breast Cancer: A Prospective Study With 7-Year Follow-up
Javier Jaén,G. Vazquez,Enrique Alonso,Maria D. De Las Peñas,Laura Díaz,Manuel Heras,José F. Pérez-Regadera +6 more
TL;DR: The study of reproducible subclinical parameters, such as PFT values, shows how their figures decrease in the first 2 years but practically recover their baseline values in the long term.
33
Radiation oncology: future needs and equipment. Current situation in Spain.
TL;DR: A calculation model is presented for estimating the number of irradiation units required to guarantee equitable cover for radiotherapeutic treatment in Spain and the number available in 2004 is clearly lower than the number desirable.
17
Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases.
Ana Mañas,Francesc Casas,Juan Pablo Ciria,Concha López,Juan C. Sáez,Amalia Palacios,Manuel Heras,Carmen Porto,Elena Sánchez,Carmen Martín,Ricardo Esco,C. Veiras,José C. Martínez,Magdalena Márquez,Alfedo Ramos,Felipe A. Calvo,Javier Fuertes,Francisco Andreu,Jorge E. Contreras,Leopoldo Pérez,Jesús Romero,Jordi Vayreda,Concepción Victoria +22 more
TL;DR: The two groups achieved similar levels of pain control in supine, seated and standing positions, and quality of life improved in both groups, however, the higher dose in combination with zoledronic acid is associated with a longer period without skeletal events.
15
Clinical and technological transition in breast cancer
TL;DR: This article is a summary of the conference "Clinical and technological transition in breast cancer" that took place in the Congress of the Spanish Society of Radiation Oncology, placed in Vigo (Spain) on June 21, 2013.
12